Bimekizumab vs Enalapril

Bimekizumab vs Enalapril: Overview

This comparison examines the pharmacological differences between Bimekizumab and Enalapril.

Mechanism of Action

Enalapril: Prodrug converted to enalaprilat; inhibits ACE preventing angiotensin I to II conversion.

Pharmacokinetics

Half-life: Enalapril — 11 hours.

Chemical Properties

Molecular Formula: Enalapril — C20H28N2O5.

Molecular Weight: Enalapril — 376.4470 g/mol.

Type: Bimekizumab — Antibody; Enalapril — Small molecule.